Global Pembrolizumab Sales Market Report 2016

November 2016 | 105 pages | ID: GAAC3D5F609EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pembrolizumab

Revenue, means the sales value of Pembrolizumab

This report studies sales (consumption) of Pembrolizumab in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Merck & Co., Inc.
• Novartis AG
• Onxeo SA
• Sumitomo Dainippon Pharma Co., Ltd.
• Taiwan Liposome Company, Ltd.
• Tiziana Life Sciences Plc

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Pembrolizumab in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Pembrolizumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Pembrolizumab Sales Market Report 2016

1 PEMBROLIZUMAB OVERVIEW

1.1 Product Overview and Scope of Pembrolizumab
1.2 Classification of Pembrolizumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pembrolizumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Pembrolizumab Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Pembrolizumab (2011-2021)
  1.5.1 Global Pembrolizumab Sales and Growth Rate (2011-2021)
  1.5.2 Global Pembrolizumab Revenue and Growth Rate (2011-2021)

2 GLOBAL PEMBROLIZUMAB COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Pembrolizumab Market Competition by Manufacturers
  2.1.1 Global Pembrolizumab Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Pembrolizumab Revenue and Share by Manufacturers (2011-2016)
2.2 Global Pembrolizumab (Volume and Value) by Type
  2.2.1 Global Pembrolizumab Sales and Market Share by Type (2011-2016)
  2.2.2 Global Pembrolizumab Revenue and Market Share by Type (2011-2016)
2.3 Global Pembrolizumab (Volume and Value) by Regions
  2.3.1 Global Pembrolizumab Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Pembrolizumab Revenue and Market Share by Regions (2011-2016)
2.4 Global Pembrolizumab (Volume) by Application

3 UNITED STATES PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 United States Pembrolizumab Sales and Value (2011-2016)
  3.1.1 United States Pembrolizumab Sales and Growth Rate (2011-2016)
  3.1.2 United States Pembrolizumab Revenue and Growth Rate (2011-2016)
  3.1.3 United States Pembrolizumab Sales Price Trend (2011-2016)
3.2 United States Pembrolizumab Sales and Market Share by Manufacturers
3.3 United States Pembrolizumab Sales and Market Share by Type
3.4 United States Pembrolizumab Sales and Market Share by Application

4 CHINA PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 China Pembrolizumab Sales and Value (2011-2016)
  4.1.1 China Pembrolizumab Sales and Growth Rate (2011-2016)
  4.1.2 China Pembrolizumab Revenue and Growth Rate (2011-2016)
  4.1.3 China Pembrolizumab Sales Price Trend (2011-2016)
4.2 China Pembrolizumab Sales and Market Share by Manufacturers
4.3 China Pembrolizumab Sales and Market Share by Type
4.4 China Pembrolizumab Sales and Market Share by Application

5 EUROPE PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Pembrolizumab Sales and Value (2011-2016)
  5.1.1 Europe Pembrolizumab Sales and Growth Rate (2011-2016)
  5.1.2 Europe Pembrolizumab Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Pembrolizumab Sales Price Trend (2011-2016)
5.2 Europe Pembrolizumab Sales and Market Share by Manufacturers
5.3 Europe Pembrolizumab Sales and Market Share by Type
5.4 Europe Pembrolizumab Sales and Market Share by Application

6 JAPAN PEMBROLIZUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Pembrolizumab Sales and Value (2011-2016)
  6.1.1 Japan Pembrolizumab Sales and Growth Rate (2011-2016)
  6.1.2 Japan Pembrolizumab Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Pembrolizumab Sales Price Trend (2011-2016)
6.2 Japan Pembrolizumab Sales and Market Share by Manufacturers
6.3 Japan Pembrolizumab Sales and Market Share by Type
6.4 Japan Pembrolizumab Sales and Market Share by Application

7 GLOBAL PEMBROLIZUMAB MANUFACTURERS ANALYSIS

7.1 Merck & Co., Inc.
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Pembrolizumab Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Novartis AG
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 105 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Onxeo SA
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 124 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Sumitomo Dainippon Pharma Co., Ltd.
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Nov Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Taiwan Liposome Company, Ltd.
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Tiziana Life Sciences Plc
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview

8 PEMBROLIZUMAB MAUFACTURING COST ANALYSIS

8.1 Pembrolizumab Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Pembrolizumab

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Pembrolizumab Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL PEMBROLIZUMAB MARKET FORECAST (2016-2021)

12.1 Global Pembrolizumab Sales, Revenue Forecast (2016-2021)
12.2 Global Pembrolizumab Sales Forecast by Regions (2016-2021)
12.3 Global Pembrolizumab Sales Forecast by Type (2016-2021)
12.4 Global Pembrolizumab Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pembrolizumab
Table Classification of Pembrolizumab
Figure Global Sales Market Share of Pembrolizumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Pembrolizumab
Figure Global Sales Market Share of Pembrolizumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure China Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Europe Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Japan Pembrolizumab Revenue and Growth Rate (2011-2021)
Figure Global Pembrolizumab Sales and Growth Rate (2011-2021)
Figure Global Pembrolizumab Revenue and Growth Rate (2011-2021)
Table Global Pembrolizumab Sales of Key Manufacturers (2011-2016)
Table Global Pembrolizumab Sales Share by Manufacturers (2011-2016)
Figure 2015 Pembrolizumab Sales Share by Manufacturers
Figure 2016 Pembrolizumab Sales Share by Manufacturers
Table Global Pembrolizumab Revenue by Manufacturers (2011-2016)
Table Global Pembrolizumab Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Pembrolizumab Revenue Share by Manufacturers
Table 2016 Global Pembrolizumab Revenue Share by Manufacturers
Table Global Pembrolizumab Sales and Market Share by Type (2011-2016)
Table Global Pembrolizumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Pembrolizumab by Type (2011-2016)
Figure Global Pembrolizumab Sales Growth Rate by Type (2011-2016)
Table Global Pembrolizumab Revenue and Market Share by Type (2011-2016)
Table Global Pembrolizumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pembrolizumab by Type (2011-2016)
Figure Global Pembrolizumab Revenue Growth Rate by Type (2011-2016)
Table Global Pembrolizumab Sales and Market Share by Regions (2011-2016)
Table Global Pembrolizumab Sales Share by Regions (2011-2016)
Figure Sales Market Share of Pembrolizumab by Regions (2011-2016)
Figure Global Pembrolizumab Sales Growth Rate by Regions (2011-2016)
Table Global Pembrolizumab Revenue and Market Share by Regions (2011-2016)
Table Global Pembrolizumab Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Pembrolizumab by Regions (2011-2016)
Figure Global Pembrolizumab Revenue Growth Rate by Regions (2011-2016)
Table Global Pembrolizumab Sales and Market Share by Application (2011-2016)
Table Global Pembrolizumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Pembrolizumab by Application (2011-2016)
Figure Global Pembrolizumab Sales Growth Rate by Application (2011-2016)
Figure United States Pembrolizumab Sales and Growth Rate (2011-2016)
Figure United States Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure United States Pembrolizumab Sales Price Trend (2011-2016)
Table United States Pembrolizumab Sales by Manufacturers (2011-2016)
Table United States Pembrolizumab Market Share by Manufacturers (2011-2016)
Table United States Pembrolizumab Sales by Type (2011-2016)
Table United States Pembrolizumab Market Share by Type (2011-2016)
Table United States Pembrolizumab Sales by Application (2011-2016)
Table United States Pembrolizumab Market Share by Application (2011-2016)
Figure China Pembrolizumab Sales and Growth Rate (2011-2016)
Figure China Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure China Pembrolizumab Sales Price Trend (2011-2016)
Table China Pembrolizumab Sales by Manufacturers (2011-2016)
Table China Pembrolizumab Market Share by Manufacturers (2011-2016)
Table China Pembrolizumab Sales by Type (2011-2016)
Table China Pembrolizumab Market Share by Type (2011-2016)
Table China Pembrolizumab Sales by Application (2011-2016)
Table China Pembrolizumab Market Share by Application (2011-2016)
Figure Europe Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Europe Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Europe Pembrolizumab Sales Price Trend (2011-2016)
Table Europe Pembrolizumab Sales by Manufacturers (2011-2016)
Table Europe Pembrolizumab Market Share by Manufacturers (2011-2016)
Table Europe Pembrolizumab Sales by Type (2011-2016)
Table Europe Pembrolizumab Market Share by Type (2011-2016)
Table Europe Pembrolizumab Sales by Application (2011-2016)
Table Europe Pembrolizumab Market Share by Application (2011-2016)
Figure Japan Pembrolizumab Sales and Growth Rate (2011-2016)
Figure Japan Pembrolizumab Revenue and Growth Rate (2011-2016)
Figure Japan Pembrolizumab Sales Price Trend (2011-2016)
Table Japan Pembrolizumab Sales by Manufacturers (2011-2016)
Table Japan Pembrolizumab Market Share by Manufacturers (2011-2016)
Table Japan Pembrolizumab Sales by Type (2011-2016)
Table Japan Pembrolizumab Market Share by Type (2011-2016)
Table Japan Pembrolizumab Sales by Application (2011-2016)
Table Japan Pembrolizumab Market Share by Application (2011-2016)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. Pembrolizumab Global Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis AG Pembrolizumab Global Market Share (2011-2016)
Table Onxeo SA Basic Information List
Table Onxeo SA Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Onxeo SA Pembrolizumab Global Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Co., Ltd. Basic Information List
Table Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sumitomo Dainippon Pharma Co., Ltd. Pembrolizumab Global Market Share (2011-2016)
Table Taiwan Liposome Company, Ltd. Basic Information List
Table Taiwan Liposome Company, Ltd. Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Taiwan Liposome Company, Ltd. Pembrolizumab Global Market Share (2011-2016)
Table Tiziana Life Sciences Plc Basic Information List
Table Tiziana Life Sciences Plc Pembrolizumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Tiziana Life Sciences Plc Pembrolizumab Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pembrolizumab
Figure Manufacturing Process Analysis of Pembrolizumab
Figure Pembrolizumab Industrial Chain Analysis
Table Raw Materials Sources of Pembrolizumab Major Manufacturers in 2015
Table Major Buyers of Pembrolizumab
Table Distributors/Traders List
Figure Global Pembrolizumab Sales and Growth Rate Forecast (2016-2021)
Figure Global Pembrolizumab Revenue and Growth Rate Forecast (2016-2021)
Table Global Pembrolizumab Sales Forecast by Regions (2016-2021)
Table Global Pembrolizumab Sales Forecast by Type (2016-2021)
Table Global Pembrolizumab Sales Forecast by Application (2016-2021 )